Latest Cash Reserves News

Austco Healthcare has delivered record FY26 financial results, driven by strong organic growth, acquisitions, and a growing software maintenance base, positioning the company for sustained earnings momentum.

Rhythm Biosciences marked its transition to commercialisation with first sales of ColoSTAT® and geneType™ tests, despite a 55% increase in loss to $5.93 million. The company expanded market access and secured manufacturing agreements, while NHS England began evaluating ColoSTAT® for bowel cancer screening.

Acorn Capital Investment Fund Limited posted a 35% drop in profit after tax to $6.25 million for FY2026, while its portfolio outperformed the Small Ords benchmark with a 9.8% return. The company declared fully franked dividends of 3.5 cents per share.

Clarity Pharmaceuticals reported a 67% increase in net loss to $107.2 million for FY26, driven by higher R&D spending, while advancing multiple Phase III trials and expanding manufacturing capacity ahead of commercialisation.

Clinuvel Pharmaceuticals marked its tenth consecutive profit with stable revenues and rising cash reserves, while accelerating U.S. expansion including a Nasdaq uplisting and potential ASX delisting.

BlackWall Limited posted a $2.4 million statutory loss for FY2026, driven by operating setbacks and unrealised asset write-downs. The company suspends dividends after exhausting franking credits and proposes a share buy-back offering WOT securities in lieu of cash.

Global Health Limited trimmed its FY26 net loss by 12.5% to A$758,220, driven by a 5.5% lift in recurring SaaS revenue and a 20% cut in employee costs aided by AI integration, though going concern risks remain.

Aerometrex delivered a landmark FY26 with operating revenue up 12.3% to $26.84 million and EBITDA more than doubling to $7.68 million, driven by a 27.2% jump in MetroMap subscription revenue and a 37.8% rise in Annual Contract Value.

Integrated Research’s FY26 results reveal a sharp 91% drop in net profit amid softer renewals and rising expenses, offset by a 27% jump in cash and a special dividend. The company pushes forward with AI-powered products despite early-stage commercialisation risks.

Solution Dynamics Limited reported an 85% drop in net profit for FY2026 to NZD 0.38 million, hit by a major contract loss and investment in its new AI-driven dental marketing platform, nGAGE.

Experience Co posted a modest 2% revenue rise to $129.6 million in FY26, but underlying EBITDA slipped 8% due to weather disruptions, inflationary pressures, and industrial action. The company is advancing a $65 million deal to combine its Skydive business with Inflite Group.

Kalina Power (ASX:KPO) swung to a AUD 15.8 million net profit in FY2026, driven by a CAD 18 million sale of megawatt allocation, lifting its balance sheet and cash reserves sharply.